Evidence map›Paper›PMID 36229507›Full record

ArticleScientific reports2022

A comparative analysis of SARS-CoV-2 viral load across different altitudes.

Esteban Ortiz-Prado, Raul Fernandez-Naranjo, Jorge Eduardo Vásconez, Alexander Paolo Vallejo-Janeta, Diana Morales-Jadan, Ismar A Rivera-Olivero, Tannya Lozada, Gines Viscor, Miguel Angel Garcia-Bereguiain, UDLA-COVID-19 team

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Esteban Ortiz-PradoOne Health Research Group, Faculty of Medicine, Universidad de Las Americas, Calle de los Colimes y Avenida De los Granados, 17013, Quito, Ecuador. e.ortizprado@gmail.com.
Raul Fernandez-NaranjoOne Health Research Group, Faculty of Medicine, Universidad de Las Americas, Calle de los Colimes y Avenida De los Granados, 17013, Quito, Ecuador.
Jorge Eduardo VásconezOne Health Research Group, Faculty of Medicine, Universidad de Las Americas, Calle de los Colimes y Avenida De los Granados, 17013, Quito, Ecuador.
Alexander Paolo Vallejo-JanetaOne Health Research Group, Faculty of Medicine, Universidad de Las Americas, Calle de los Colimes y Avenida De los Granados, 17013, Quito, Ecuador.
Diana Morales-JadanDecanato de Investigación y Vinculación, Universidad de Las Americas, Quito, Ecuador.
Ismar A Rivera-OliveroOne Health Research Group, Faculty of Medicine, Universidad de Las Americas, Calle de los Colimes y Avenida De los Granados, 17013, Quito, Ecuador.
Tannya LozadaFacultad de Ciencias de la Salud, Universidad Latina de Costa Rica, San Pedro, Costa Rica.
Gines ViscorDepartment of Cell Biology, Physiology, and Immunology of the Faculty of Biology, Universitat de Barcelona, Barcelona, Spain.
Miguel Angel Garcia-BereguiainOne Health Research Group, Faculty of Medicine, Universidad de Las Americas, Calle de los Colimes y Avenida De los Granados, 17013, Quito, Ecuador.
UDLA-COVID-19 team
Universidad de Las Américas · ECLatin University of Costa Rica · CRUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 has spread throughout the world, including areas located at high or very high altitudes. There is a debate about the role of high altitude hypoxia on viral transmission, incidence, and COVID-19 related mortality. This is the first comparison of SARS-CoV-2 viral load across elevations ranging from 0 to 4300 m. To describe the SARS-CoV-2 viral load across samples coming from 62 cities located at low, moderate, high, and very high altitudes in Ecuador. An observational analysis of viral loads among nasopharyngeal swap samples coming from a cohort of 4929 patients with a RT-qPCR test positive for SARS-CoV-2. The relationship between high and low altitude only considering our sample of 4929 persons is equal in both cases and not significative (p-value 0.19). In the case of low altitude, adding the sex variable to the analysis, it was possible to find a significative difference between men and women (p-value < 0.05). Considering initially sex and then altitude, it was possible to find a significative difference between high and low altitude for men (p-value 0.05). There is not enough evidence to state that viral load is affected directly by altitude range but adding a new variable as sex in the analysis shows that the presence of new variables influences the relationship of altitude range and viral load. There is no evidence that viral loads (Ct and copies/ml) differ at low or high altitude. Using sex as a co-factor, we found that men have higher viral loads than women at low and moderate altitude locations, while living at high altitude, no differences were found. When Ct values were aggregated by low, moderate, and high viral load, we found no significant differences when sex was excluded from the analysis. We conclude that viral load is not directly affected by altitude, but COVID-19 incidence and mortality are rather affected by socio-demographic and idiosyncratic dynamics.

Indexed as

COVID-19SARS-CoV-2AltitudeFemaleHumansMaleNasopharynxViral Load

Identifiers

PMID36229507
PMCPMC9558017
OpenAlexW4304893316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.